.svg){kind=small}
Market Insights Snapshot
Quality Drugs concentrated entirely in Edible during May 2026, with Edible holding 100.0% mix and a category YoY sales change of 22.6% alongside a MoM decline of 6.4%. The brand’s average price of $6.14 sat 10.5% lower YoY while category sales still expanded 22.6% YoY, and within Oregon Edible the brand held rank 10. This combination of a full Edible allocation at 100.0% share and a rank of 10 implies Quality Drugs is trading price for volume within a single-category bet that lifted annual velocity while softening sequential momentum.
With a 22.6% YoY rise in its sole category alongside a 6.4% MoM dip, Quality Drugs is positioned as a value-leaning Edible player whose monthly volatility is more sensitive to near-term demand than to annual trend. Holding rank 10 in Oregon Edible while posting a 10.5% YoY price reduction suggests headroom to trade up or diversify; the current 100.0% category mix concentrates execution risk and caps cross-category share capture.
Competitive Landscape
Quality Drugs sits at rank #10 in OR Edible in May 2026 with a 0-position year-over-year rank change, and its three-month trend also holds at #10 while its peak was #8 in April 2025; meanwhile, Wyld remains #1 with a -3.16% YoY sales change and Good Tide climbed from #5 to #4 as Mule Extracts slipped from #4 to #5 with a -16.98% YoY sales change, indicating competitors are reshuffling above a static Quality Drugs. With Gron / Grön steady at #2 alongside a -0.67% YoY sales move and Drops fixed at #3 despite a -12.88% YoY sales change, the stability of Quality Drugs’ #10 position amid mixed declines in the top three and rank churn at #4–#5 implies a holding pattern where incremental share gains are available if Quality Drugs can convert volatility above it into upward movement.
Notable Products
Watermelon Gummy (100mg) led May 2026 with a 56.9% month-over-month surge to rank 1, while Cosmic Pop Gummy (100mg) fell 43.3% and slid to rank 2, signaling a sharp intra-portfolio rotation. Assorted Caramels 10-Pack (100mg) declined 9.0% at rank 7 as the CBD/CBN/THC 1:1:1 Berry Bonanza Gumdrops 10-Pack (100mg CBD, 100mg CBN, 100mg THC) dropped 14.6% at rank 8, indicating mixed momentum beneath the top line. Nine of the top ten are Edible SKUs, with multiple fruit-flavor gummies occupying ranks 1 through 6, concentrating demand in flavor-led confections rather than functional blends. The pattern implies Quality Drugs is tilting toward high-velocity fruit gummies, prioritizing classic THC formats over multi-cannabinoid formulations.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
